Clinical Trial Update: Interbody Systems: Post Market Clinical Follow-up Study

View source ↗

Summary

A post-market clinical follow-up study of interbody spinal implants (Interbody Systems) by K2M, Inc. for degenerative disc disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Interbody Systems

Snippet

Sponsor: K2M, Inc. | Conditions: Degenerative Disc Disease | Status: TERMINATED